Key result
Statin therapy cuts major cardiovascular events ~25% in adherent women despite persistent implementation barriers.
Answers are grounded in this paper and cite their sources.
This review highlights the need to overcome sociocultural barriers and myths to improve statin adherence and cardiovascular outcomes among Indian women with dyslipidemia.
Dyslipidemia has become one of the most common metabolic abnormalities among Indian women and a major contributor to the growing burden of cardiovascular disease. Although statins are well established as effective lipid-lowering drugs, their use in Indian women remains inconsistent and delayed. Meta-analyses show a 22–30% reduction in major cardiovascular events among women adherent to statin therapy. Myths about infertility, hepatic damage, muscle weakness, and bone loss, together with sociocultural and economic barriers, have limited their acceptance. This narrative review summarizes evidence from 2010 to 2025 drawn from randomized trials, meta-analyses, registry data, and Indian observational studies. It highlights gender-specific differences in lipid patterns, efficacy, tolerability, and adherence and integrates pharmacological and lifestyle approaches relevant to Indian practice. Combining statin therapy with improved diet, selected nutraceuticals, yoga, and psychosocial counselling can enhance adherence and outcomes. Strengthening gender-aware prescribing and culturally compatible education can help close the treatment gap between Indian and global populations.
No takes yet. Share an insight, caveat, or question.
Nousheen et al. (2025) conducted a review in Dyslipidemia. Statin therapy was evaluated on Major cardiovascular events (22-30% reduction). Statin therapy reduces major cardiovascular events by 22–30% among adherent women, but its use in Indian women remains inconsistent due to sociocultural barriers and myths.
Synapse has enriched 10 related papers. Consider them for comparative context: